Ypsomed
Simon Bosshard is an experienced lead innovation engineer at Ypsomed AG since May 2018, focusing on innovation within Ypsomed Delivery Systems after previously working as a development engineer in the diabetes care sector. Additional roles include serving as a visiting lecturer at Berner Fachhochschule BFH in the Department of Engineering and Information Technology since August 2023, and a former development engineer at DePuy Synthes Companies in the R&D Trauma/CMF division from April 2015 to April 2018. Simon Bosshard holds a Master of Science in Biomedical Engineering from the University of Bern and a Bachelor of Science in Mechanical Engineering from Berner Fachhochschule BFH, complemented by formative experiences in polymechanics and technical education at Saia-Burgess Murten AG and Rewa-Technik AG.
This person is not in any teams
This person is not in any offices
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.